Go to top of page

Executive management and structure

The APVMA management structure (APVMA organisation structure as at 30 June 2019) supports effective operation, communication and strategic understanding at all levels of the organisation.

APVMA organisation structure as at 30 June 2019

Chief Executive Officer

Office of the Chief Executive Officer

Deputy Chief Executive Officer

Finance and Procurement

Human Resources and Development

Relocation Operations


Information and Communications Technology


Parliamentary Processes

Executive Director, Risk Assessment Capability

Chemistry and Manufacture

Efficacy and Safety



Residues and Trade

Executive Director, Registration Management

Case Management and Administration

Veterinary Medicines


Minor Use

Executive Director, Service Improvement and Integration

Relocation and Enabling Technologies

Chief Regulatory Scientist

Chemical Review

Science Quality

Adverse Experience Reporting

Compliance and Monitoring

Manufacturing Quality and Licensing

Hormone Growth Promotant Licensing

Learning and Development

General Counsel


The APVMA Executive Leadership Team is responsible for business performance and managing agency compliance with legislative requirements. It oversees the development of key corporate plans and strategies, monitors and reviews organisational performance and risk, and ensures that we meet our regulatory obligations. The executive team and APVMA staff use their collective skills and experience to develop and consider strategic initiatives and operational issues.

Dr Chris Parker, APVMA Chief Executive Officer

Dr Chris Parker

Chief Executive Officer

The Chief Executive Officer (CEO) is the accountable authority responsible for APVMA governance and management, including the exercise of the APVMA’s powers and functions. The CEO consults with key stakeholders to set the organisation’s vision, objectives and strategies to meet its legislative responsibilities. The CEO approves the APVMA’s corporate and operational plans and budgets, monitors financial and operational performance, and oversees program performance. The CEO leads the authority’s engagement efforts, particularly its engagement with key international agencies.

Ms Lisa Croft, APVMA Deputy Chief Executive Officer

Ms Lisa Croft

Deputy Chief Executive Officer

The Deputy CEO provides strategic advice to the CEO and executive oversight of Corporate Services and the regulatory science, postmarket and reform functions of the APVMA. Key responsibilities include overseeing the APVMA business operating model; preparing financial plans, budgets and strategies that enable the APVMA to deliver quality services with the funds available; and managing people services, risk management, stakeholder engagement, records management, and physical and personnel security.

Dr Jason Lutze, APVMA Executive Director, Risk Assessment Capability

Dr Jason Lutze

Executive Director, Risk Assessment Capability

The Executive Director (ED) Risk Assessment Capability manages the expert assessment areas of the APVMA, including Chemistry and Manufacture, Efficacy and Safety, Environment, Residues and Trade and Health Assessment teams. Responsibilities also include continuously improving data guidelines and the quality of the assessments contributing to registration.

Mr Alan Norden, APVMA Executive Director, Registration Management and Evaluation

Mr Alan Norden

Executive Director, Registration Management and Evaluation

The ED Registration Management and Evaluation manages the assessment process for agricultural chemicals and veterinary medicines. Responsibilities include managing Pre-Application Assistance, Preliminary Assessment and evaluation of product registration, permits, export certificates and import consents.

Mr Bob Smith, APVMA Executive Director, Service Improvement and Integration

Mr Bob Smith

Executive Director, Service Improvement and Integration

The ED Service Improvement and Integration is responsible for ensuring that the objectives of the APVMA digital strategy are met to support the transition to the APVMA Armidale business model, including overseeing the linkages to established business systems and the transition from these systems to new platforms. Key responsibilities include overseeing planning, scheduling and delivery of the logistics of the relocation, and ensuring appropriate risk management, procurement, governance and record keeping arrangements are in place.

Dr Maggie Hardy, APVMA Chief Regulatory Scientist

Dr Maggie Hardy

Chief Regulatory Scientist

The Chief Regulatory Scientist ensures the continued high quality of the APVMA’s scientific decision making through two functions: Science Quality (responsible for the Learning and Development framework and Knowledge Management) and postmarket activities (including the Adverse Experience Reporting Program, Chemical Review, Compliance and Monitoring, and Manufacturing Quality and Licensing). Responsibilities also include providing the CEO and senior staff with independent, expert advice on regulatory decisions and scientific aspects of the APVMA’s regulatory framework, and delivering the International Engagement Strategy.

Mr Dwayne Currie, APVMA General Counsel

Mr Dwayne Currie

General Counsel

The General Counsel provides and oversees the provision of legal advice and assistance, providing support to the CEO, the Executive Leadership Team and staff on all aspects of the APVMA’s administrative and regulatory requirements. Responsibilities include providing high-level and strategic legal advice, particularly on significant issues that may have agency-wide implications.